Literature DB >> 23643749

Dopamine D(3) receptor deletion or blockade attenuates cocaine-induced conditioned place preference in mice.

Rui Song1, Hai-Ying Zhang, Xiao-Qing Peng, Rui-Bin Su, Ri-Fang Yang, Jin Li, Zheng-Xiong Xi, Eliot L Gardner.   

Abstract

The dopamine (DA) D3 receptor (D3R) has received much attention in medication development for treatment of addiction. However, the functional role of the D3R in drug reward and addiction has been a matter of debate. We recently reported that D3 receptor-knockout (D3(-/-)) mice display increased vulnerability to cocaine self-administration, which we interpret as a compensatory response to attenuated cocaine reward after D3R deletion. Here we report that D3(-/-) mice displayed attenuated cocaine-induced conditioned place response (CPP) compared to wild-type mice. Similarly, blockade of brain D3Rs by YQA-14, a novel DA D3 receptor antagonist, significantly and dose-dependently inhibits acquisition and expression of cocaine-induced CPP in WT mice, but not in D3(-/-) mice. These findings suggest that: 1) D3Rs play an important role in mediating cocaine's rewarding effects; and 2) YQA-14 is a highly potent and selective D3R antagonist in vivo, which deserves further study as a candidate for treatment of cocaine addiction. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23643749      PMCID: PMC3742042          DOI: 10.1016/j.neuropharm.2013.04.042

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  36 in total

1.  The novel dopamine D3 receptor antagonist NGB 2904 inhibits cocaine's rewarding effects and cocaine-induced reinstatement of drug-seeking behavior in rats.

Authors:  Zheng-Xiong Xi; Amy Hauck Newman; Jeremy G Gilbert; Arlene C Pak; Xiao-Qing Peng; Charles R Ashby; Leah Gitajn; Eliot L Gardner
Journal:  Neuropsychopharmacology       Date:  2005-10-05       Impact factor: 7.853

Review 2.  Neurobiology of addiction.

Authors:  R A Wise
Journal:  Curr Opin Neurobiol       Date:  1996-04       Impact factor: 6.627

3.  D3 receptor binding in human brain during cocaine overdose.

Authors:  D C Mash
Journal:  Mol Psychiatry       Date:  1997-01       Impact factor: 15.992

4.  Increased vulnerability to cocaine in mice lacking dopamine D3 receptors.

Authors:  Rui Song; Hai-Ying Zhang; Xia Li; Guo-Hua Bi; Eliot L Gardner; Zheng-Xiong Xi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-08       Impact factor: 11.205

Review 5.  Dopamine receptor pharmacology.

Authors:  P Seeman; H H Van Tol
Journal:  Trends Pharmacol Sci       Date:  1994-07       Impact factor: 14.819

6.  Pretreatment with the dopamine agonist 7-OH-DPAT shifts the cocaine self-administration dose-effect function to the left under different schedules in the rat.

Authors:  S.B. Caine; G.F. Koob
Journal:  Behav Pharmacol       Date:  1995-06       Impact factor: 2.293

7.  Activation of dopamine D3 receptors inhibits reward-related learning induced by cocaine.

Authors:  H Kong; W Kuang; S Li; M Xu
Journal:  Neuroscience       Date:  2010-12-16       Impact factor: 3.590

8.  Dopamine D3 receptor mutant mice exhibit increased behavioral sensitivity to concurrent stimulation of D1 and D2 receptors.

Authors:  M Xu; T E Koeltzow; G T Santiago; R Moratalla; D C Cooper; X T Hu; N M White; A M Graybiel; F J White; S Tonegawa
Journal:  Neuron       Date:  1997-10       Impact factor: 17.173

9.  D3 dopamine and kappa opioid receptor alterations in human brain of cocaine-overdose victims.

Authors:  D C Mash; J K Staley
Journal:  Ann N Y Acad Sci       Date:  1999-06-29       Impact factor: 5.691

10.  Neurochemical and functional characterization of the preferentially selective dopamine D3 agonist PD 128907.

Authors:  T A Pugsley; M D Davis; H C Akunne; R G MacKenzie; Y H Shih; G Damsma; H Wikstrom; S Z Whetzel; L M Georgic; L W Cooke
Journal:  J Pharmacol Exp Ther       Date:  1995-12       Impact factor: 4.030

View more
  17 in total

1.  Examining the role of dopamine D2 and D3 receptors in Pavlovian conditioned approach behaviors.

Authors:  Kurt M Fraser; Joshua L Haight; Eliot L Gardner; Shelly B Flagel
Journal:  Behav Brain Res       Date:  2016-02-22       Impact factor: 3.332

2.  Blockade of D3 receptors by YQA14 inhibits cocaine's rewarding effects and relapse to drug-seeking behavior in rats.

Authors:  Rui Song; Guo-Hua Bi; Hai-Ying Zhang; Ri-Fang Yang; Eliot L Gardner; Jin Li; Zheng-Xiong Xi
Journal:  Neuropharmacology       Date:  2013-10-28       Impact factor: 5.250

3.  Cocaine reward and memory after chemogenetic inhibition of distinct serotonin neuron subtypes in mice.

Authors:  Britahny M Baskin; Jia Jia Mai; Susan M Dymecki; Kathleen M Kantak
Journal:  Psychopharmacology (Berl)       Date:  2020-06-03       Impact factor: 4.530

4.  Newly Developed Dopamine D3 Receptor Antagonists, R-VK4-40 and R-VK4-116, Do Not Potentiate Cardiovascular Effects of Cocaine or Oxycodone in Rats.

Authors:  Chloe J Jordan; Bree A Humburg; Eric B Thorndike; Anver Basha Shaik; Zheng-Xiong Xi; Michael H Baumann; Amy Hauck Newman; Charles W Schindler
Journal:  J Pharmacol Exp Ther       Date:  2019-09-27       Impact factor: 4.030

5.  The highly selective dopamine D3R antagonist, R-VK4-40 attenuates oxycodone reward and augments analgesia in rodents.

Authors:  Chloe J Jordan; Bree Humburg; Myra Rice; Guo-Hua Bi; Zhi-Bing You; Anver Basha Shaik; Jianjing Cao; Alessandro Bonifazi; Alexandra Gadiano; Rana Rais; Barbara Slusher; Amy Hauck Newman; Zheng-Xiong Xi
Journal:  Neuropharmacology       Date:  2019-04-08       Impact factor: 5.250

6.  Positive Allosteric Modulation of Cannabinoid Receptor Type 1 Suppresses Pathological Pain Without Producing Tolerance or Dependence.

Authors:  Richard A Slivicki; Zhili Xu; Pushkar M Kulkarni; Roger G Pertwee; Ken Mackie; Ganesh A Thakur; Andrea G Hohmann
Journal:  Biol Psychiatry       Date:  2017-07-08       Impact factor: 13.382

7.  Dopamine D3R antagonist VK4-116 attenuates oxycodone self-administration and reinstatement without compromising its antinociceptive effects.

Authors:  Zhi-Bing You; Guo-Hua Bi; Ewa Galaj; Vivek Kumar; Jianjing Cao; Alexandra Gadiano; Rana Rais; Barbara S Slusher; Eliot L Gardner; Zheng-Xiong Xi; Amy Hauck Newman
Journal:  Neuropsychopharmacology       Date:  2018-11-27       Impact factor: 7.853

8.  The dopamine D3 receptor antagonist, SR 21502, facilitates extinction of cocaine conditioned place preference.

Authors:  E Galaj; J Haynes; R Nisanov; S Ananthan; R Ranaldi
Journal:  Drug Alcohol Depend       Date:  2015-12-10       Impact factor: 4.492

9.  The selective dopamine D3 receptor antagonist, SR 21502, reduces cue-induced reinstatement of heroin seeking and heroin conditioned place preference in rats.

Authors:  Ewa Galaj; Monica Manuszak; Sandra Babic; Subramaniam Ananthan; Robert Ranaldi
Journal:  Drug Alcohol Depend       Date:  2015-09-25       Impact factor: 4.492

Review 10.  Beyond small-molecule SAR: using the dopamine D3 receptor crystal structure to guide drug design.

Authors:  Thomas M Keck; Caitlin Burzynski; Lei Shi; Amy Hauck Newman
Journal:  Adv Pharmacol       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.